Trupanion Inc. reported fourth‑quarter 2025 revenue of $376.9 million, a 12% year‑over‑year increase that surpassed the consensus estimate of $375.8 million by $1.1 million. Earnings per share were $0.13, falling $0.01 short of the $0.14 estimate and representing a miss of roughly 7–10% depending on the analyst source. The revenue beat was driven by a 15% rise in subscription revenue to $261.4 million, while the EPS miss was attributed to higher operating costs and the impact of rising veterinary inflation, which weighed on profitability.
The subscription segment continued to expand, with 1,096,173 pets enrolled in Q4 2025—up 5% from 1,041,212 in Q4 2024. Free cash flow rose to $25.3 million, up from $21.8 million in the prior year, and the adjusted operating margin for subscriptions climbed to 16.5% from 15.3% in Q4 2024, reflecting improved pricing power and cost discipline. These metrics underscore a solid core business that is scaling while maintaining healthy margins.
Management guidance for the first quarter of 2026 projects total revenue of $376 million to $382 million and subscription revenue of $265 million to $268 million, while full‑year 2026 guidance calls for total revenue of $1.55 billion to $1.582 billion and subscription revenue of $1.117 billion to $1.137 billion. Adjusted operating income is expected to be $173 million to $187 million. The guidance signals confidence in continued double‑digit growth and margin expansion, building on the company’s recent performance.
CEO Margi Tooth highlighted the company’s scale and profitability, noting that Trupanion “has grown to support over 1 million pets and generate over $1 billion in revenue.” She added that since 2021 the firm has delivered more than $500 million in discretionary profit, growing at a 22% compound annual growth rate, and that 2025 marked a record year with $518 million in adjusted operating income and nearly 1 million pets protected. These statements illustrate the leadership’s focus on sustained growth and margin discipline.
Market reaction to the earnings was muted, with the stock trading near its 52‑week low. Investors appeared to weigh the revenue beat against the EPS miss, indicating a cautious stance that profitability remains a priority. The guidance, however, suggests that management remains optimistic about future performance, which may temper short‑term concerns.
Headwinds include rising pet acquisition costs, veterinary inflation, and increasing competition, all of which could pressure margins. Tailwinds are the underpenetrated pet‑insurance market and strategic initiatives such as the Landspath food business and claims‑automation program, which are expected to support long‑term growth and improve operational efficiency.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.